Nicholas Jason Singer 13D and 13G filings for Ernexa Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 9:30 pm Purchase | 2024-12-31 | 13G | Ernexa Therapeutics Inc. ERNA | Nicholas Jason Singer | 171,000 4.920% | 130,968 (+327.16%) | Filing |
| 2024-01-19 10:31 am Purchase | 2023-12-31 | 13G | Ernexa Therapeutics Inc. ERNA | Nicholas Jason Singer | 40,032 9.990% | 2,871 (+7.73%) | Filing |
| 2023-09-08 06:07 am Unchanged | 2023-07-06 | 13G | Ernexa Therapeutics Inc. ERNA | Nicholas Jason Singer | 37,161 9.900% | 0 (Unchanged) | Filing |
| 2023-07-26 5:05 pm Purchase | 2023-04-03 | 13D | Ernexa Therapeutics Inc. ERNA | Nicholas Jason Singer | 37,161 9.990% | 37,161 (New Position) | Filing |